Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:brand
gptkb:drug |
| gptkbp:activeIngredient |
pegaspargase
|
| gptkbp:approvalYear |
1994
|
| gptkbp:approvedBy |
gptkb:FDA
gptkb:EMA |
| gptkbp:ATCCode |
L01XX24
|
| gptkbp:contraindication |
history of severe hypersensitivity to pegaspargase
|
| gptkbp:form |
solution for injection
|
| https://www.w3.org/2000/01/rdf-schema#label |
Oncaspar
|
| gptkbp:indication |
patients allergic to native asparaginase
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Servier_Pharmaceuticals
|
| gptkbp:mechanismOfAction |
depletes asparagine
|
| gptkbp:routeOfAdministration |
intramuscular
intravenous |
| gptkbp:sideEffect |
pancreatitis
allergic reaction liver toxicity coagulation disorder |
| gptkbp:usedFor |
leukemia
|
| gptkbp:bfsParent |
gptkb:Servier_Pharmaceuticals
|
| gptkbp:bfsLayer |
7
|